 |
Acalabrutinib |
|---|---|
| Trade Name | |
| Orphan Indication | Waldenstrom macroglobulinemia |
| EU Market Approval | EU |
| EU Designation Date | 2016-03-21 00:00:00 |
| Sponsor | Acerta Pharma, BV |
| |
Acalabrutinib |
|---|---|
| Trade Name | |
| Orphan Indication | Waldenstrom macroglobulinemia |
| EU Market Approval | EU |
| EU Designation Date | 2016-03-21 00:00:00 |
| Sponsor | Acerta Pharma, BV |